# Celsius Holdings, Inc.: financial statements, quarterly

CELH · Nasdaq · CIK 1341766 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/celh.md) · [Financials](/companies/celh/financials.md) · [Filings](/companies/celh/filings.md) · [Insiders](/companies/celh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/celh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [385](/filings/0001341766-24-000093.md) | [347 d](/filings/0001341766-26-000024.md) | [356](/filings/0001341766-25-000080.md) | [402](/filings/0001341766-25-000104.md) | [266](/filings/0001341766-25-000144.md) | [332 d](/filings/0001341766-26-000024.md) | [329](/filings/0001341766-26-000039.md) | [739](/filings/0001341766-26-000050.md) | [725](/filings/0001341766-25-000144.md) | [722 d](/filings/0001341766-26-000024.md) | [783](/filings/0001341766-26-000039.md) | [818](/filings/0001341766-26-000050.md) |
| Cost of revenue | $m | [191](/filings/0001341766-24-000093.md) | [181 d](/filings/0001341766-24-000015.md) | [174](/filings/0001341766-24-000029.md) | [193](/filings/0001341766-24-000057.md) | [144](/filings/0001341766-24-000093.md) | [166 d](/filings/0001341766-26-000024.md) | [157](/filings/0001341766-26-000039.md) | [358](/filings/0001341766-26-000050.md) | [353](/filings/0001341766-25-000144.md) | [380 d](/filings/0001341766-26-000024.md) | [405](/filings/0001341766-26-000039.md) | [424](/filings/0001341766-26-000050.md) |
| Gross profit | $m | [194](/filings/0001341766-24-000093.md) | [166 d](/filings/0001341766-26-000024.md) | [182](/filings/0001341766-25-000080.md) | [209](/filings/0001341766-25-000104.md) | [122](/filings/0001341766-25-000144.md) | [167 d](/filings/0001341766-26-000024.md) | [172](/filings/0001341766-26-000039.md) | [381](/filings/0001341766-26-000050.md) | [372](/filings/0001341766-25-000144.md) | [342 d](/filings/0001341766-26-000024.md) | [378](/filings/0001341766-26-000039.md) | [394](/filings/0001341766-26-000050.md) |
| Research and development | $m | [0.5](/filings/0001341766-24-000093.md) | [0.7 d](/filings/0001341766-26-000024.md) | [0.2](/filings/0001341766-24-000029.md) | [0.2](/filings/0001341766-24-000057.md) | [0.3](/filings/0001341766-24-000093.md) | [0.2 d](/filings/0001341766-26-000024.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | [99.0](/filings/0001341766-25-000080.md) | [115](/filings/0001341766-25-000104.md) | [125](/filings/0001341766-25-000144.md) | [185 d](/filings/0001341766-26-000024.md) | [120](/filings/0001341766-26-000039.md) | [238](/filings/0001341766-26-000050.md) | [206](/filings/0001341766-25-000144.md) | [235 d](/filings/0001341766-26-000024.md) | [235](/filings/0001341766-26-000039.md) | [238](/filings/0001341766-26-000050.md) |
| Operating income | $m | [97.7](/filings/0001341766-24-000093.md) | [58.9 d](/filings/0001341766-26-000024.md) | [83.2](/filings/0001341766-25-000080.md) | [94.2](/filings/0001341766-25-000104.md) | [(3.2)](/filings/0001341766-25-000144.md) | [(18.5) d](/filings/0001341766-26-000024.md) | [52.0](/filings/0001341766-26-000039.md) | [143](/filings/0001341766-26-000050.md) | [(80.0)](/filings/0001341766-25-000144.md) | [26.1 d](/filings/0001341766-26-000024.md) | [139](/filings/0001341766-26-000039.md) | [75.3](/filings/0001341766-26-000050.md) |
| Interest expense | $m | not reported | not reported | not reported | [0.0](/filings/0001341766-25-000104.md) | [0.0](/filings/0001341766-25-000144.md) | [0.0 d](/filings/0001341766-26-000024.md) | [0.0](/filings/0001341766-26-000039.md) | [18.1](/filings/0001341766-26-000050.md) | [18.2](/filings/0001341766-25-000144.md) | [12.7 d](/filings/0001341766-26-000024.md) | [11.8](/filings/0001341766-26-000039.md) | [11.6](/filings/0001341766-26-000050.md) |
| Income tax | $m | [20.8](/filings/0001341766-24-000093.md) | [17.7 d](/filings/0001341766-26-000024.md) | [14.7](/filings/0001341766-25-000080.md) | [24.8](/filings/0001341766-25-000104.md) | [1.8](/filings/0001341766-25-000144.md) | [8.7 d](/filings/0001341766-26-000024.md) | [16.6](/filings/0001341766-26-000039.md) | [29.6](/filings/0001341766-26-000050.md) | [(27.0)](/filings/0001341766-25-000144.md) | [(2.1) d](/filings/0001341766-26-000024.md) | [27.4](/filings/0001341766-26-000039.md) | [14.2](/filings/0001341766-26-000050.md) |
| Net income | $m | [83.9](/filings/0001341766-24-000093.md) | [50.1 d](/filings/0001341766-26-000024.md) | [77.8](/filings/0001341766-25-000144.md) | [79.8](/filings/0001341766-25-000144.md) | [6.4](/filings/0001341766-25-000144.md) | [(18.9) d](/filings/0001341766-26-000024.md) | [44.4](/filings/0001341766-26-000050.md) | [99.9](/filings/0001341766-26-000050.md) | [(61.0)](/filings/0001341766-25-000144.md) | [24.7 d](/filings/0001341766-26-000024.md) | [110](/filings/0001341766-26-000050.md) | [55.3](/filings/0001341766-26-000050.md) |
| Diluted EPS | $ per share | [0.30](/filings/0001341766-24-000093.md) | not reported | [0.27](/filings/0001341766-25-000080.md) | [0.28](/filings/0001341766-25-000104.md) | [0.00](/filings/0001341766-25-000144.md) | not reported | [0.15](/filings/0001341766-26-000039.md) | [0.33](/filings/0001341766-26-000050.md) | [(0.27)](/filings/0001341766-25-000144.md) | not reported | [0.33](/filings/0001341766-26-000039.md) | [0.14](/filings/0001341766-26-000050.md) |
| Basic EPS | $ per share | [0.30](/filings/0001341766-24-000093.md) | not reported | [0.28](/filings/0001341766-25-000080.md) | [0.29](/filings/0001341766-25-000104.md) | [0.00](/filings/0001341766-25-000144.md) | not reported | [0.15](/filings/0001341766-26-000039.md) | [0.33](/filings/0001341766-26-000050.md) | [(0.27)](/filings/0001341766-25-000144.md) | not reported | [0.33](/filings/0001341766-26-000039.md) | [0.14](/filings/0001341766-26-000050.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [760](/filings/0001341766-23-000035.md) | [756](/filings/0001341766-25-000024.md) | [879](/filings/0001341766-24-000029.md) | [903](/filings/0001341766-24-000057.md) | [904](/filings/0001341766-24-000093.md) | [890](/filings/0001341766-26-000024.md) | [977](/filings/0001341766-25-000080.md) | [615](/filings/0001341766-25-000104.md) | [806](/filings/0001341766-25-000144.md) | [399](/filings/0001341766-26-000050.md) | [549](/filings/0001341766-26-000039.md) | [631](/filings/0001341766-26-000050.md) |
| Current assets | $m | [1,215](/filings/0001341766-23-000035.md) | [1,205](/filings/0001341766-25-000024.md) | [1,315](/filings/0001341766-24-000029.md) | [1,385](/filings/0001341766-24-000057.md) | [1,363](/filings/0001341766-24-000093.md) | [1,325](/filings/0001341766-26-000024.md) | [1,411](/filings/0001341766-25-000080.md) | [1,391](/filings/0001341766-25-000104.md) | [1,942](/filings/0001341766-25-000144.md) | [1,811](/filings/0001341766-26-000050.md) | [1,864](/filings/0001341766-26-000039.md) | [1,876](/filings/0001341766-26-000050.md) |
| Total assets | $m | [1,546](/filings/0001341766-23-000035.md) | [1,536](/filings/0001341766-25-000024.md) | [1,646](/filings/0001341766-24-000029.md) | [1,719](/filings/0001341766-24-000057.md) | [1,704](/filings/0001341766-24-000093.md) | [1,767](/filings/0001341766-26-000024.md) | [1,860](/filings/0001341766-25-000080.md) | [3,795](/filings/0001341766-25-000104.md) | [5,266](/filings/0001341766-25-000144.md) | [5,120](/filings/0001341766-26-000050.md) | [5,158](/filings/0001341766-26-000039.md) | [5,168](/filings/0001341766-26-000050.md) |
| Current liabilities | $m | [336](/filings/0001341766-23-000035.md) | [277](/filings/0001341766-25-000024.md) | [315](/filings/0001341766-24-000029.md) | [313](/filings/0001341766-24-000057.md) | [289](/filings/0001341766-24-000093.md) | [366](/filings/0001341766-26-000024.md) | [418](/filings/0001341766-25-000080.md) | [660](/filings/0001341766-25-000104.md) | [1,029](/filings/0001341766-25-000144.md) | [1,079](/filings/0001341766-26-000050.md) | [1,051](/filings/0001341766-26-000039.md) | [1,044](/filings/0001341766-26-000050.md) |
| Total liabilities | $m | [508](/filings/0001341766-23-000035.md) | [448](/filings/0001341766-25-000024.md) | [483](/filings/0001341766-24-000029.md) | [479](/filings/0001341766-24-000057.md) | [456](/filings/0001341766-24-000093.md) | [542](/filings/0001341766-26-000024.md) | [592](/filings/0001341766-25-000080.md) | [1,704](/filings/0001341766-25-000104.md) | [2,302](/filings/0001341766-25-000144.md) | [2,178](/filings/0001341766-26-000050.md) | [2,147](/filings/0001341766-26-000039.md) | [2,209](/filings/0001341766-26-000050.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001341766-26-000024.md) | not reported | [863](/filings/0001341766-25-000104.md) | [861](/filings/0001341766-25-000144.md) | [670](/filings/0001341766-26-000050.md) | [669](/filings/0001341766-26-000039.md) | [668](/filings/0001341766-26-000050.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [9.0](/filings/0001341766-25-000104.md) | [9.0](/filings/0001341766-25-000144.md) | [7.0](/filings/0001341766-26-000050.md) | [7.0](/filings/0001341766-26-000039.md) | [7.0](/filings/0001341766-26-000050.md) |
| Shareholders' equity | $m | [213](/filings/0001341766-24-000093.md) | [264](/filings/0001341766-26-000024.md) | [338](/filings/0001341766-25-000144.md) | [416](/filings/0001341766-25-000144.md) | [424](/filings/0001341766-25-000144.md) | [400](/filings/0001341766-26-000050.md) | [443](/filings/0001341766-26-000050.md) | [1,267](/filings/0001341766-26-000050.md) | [1,203](/filings/0001341766-25-000144.md) | [1,181](/filings/0001341766-26-000050.md) | [1,251](/filings/0001341766-26-000050.md) | [1,200](/filings/0001341766-26-000050.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [90.8 d](/filings/0001341766-24-000093.md) | [5.2 d](/filings/0001341766-26-000024.md) | [135](/filings/0001341766-25-000080.md) | [39.6 d](/filings/0001341766-25-000104.md) | [12.9 d](/filings/0001341766-25-000144.md) | [75.7 d](/filings/0001341766-26-000024.md) | [103](/filings/0001341766-26-000039.md) | [43.7 d](/filings/0001341766-26-000050.md) | [332 d](/filings/0001341766-25-000144.md) | [(119) d](/filings/0001341766-26-000024.md) | [73.7](/filings/0001341766-26-000039.md) | [223 d](/filings/0001341766-26-000050.md) |
| Capital expenditure | $m | [5.9 d](/filings/0001341766-24-000093.md) | [4.7 d](/filings/0001341766-26-000024.md) | [4.5](/filings/0001341766-25-000080.md) | [9.2 d](/filings/0001341766-25-000104.md) | [4.2 d](/filings/0001341766-25-000144.md) | [5.4 d](/filings/0001341766-26-000024.md) | [6.9](/filings/0001341766-26-000039.md) | [8.3 d](/filings/0001341766-26-000050.md) | [10.3 d](/filings/0001341766-25-000144.md) | [10.5 d](/filings/0001341766-26-000024.md) | [7.9](/filings/0001341766-26-000039.md) | [17.1 d](/filings/0001341766-26-000050.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001341766-26-000024.md) | [0.0](/filings/0001341766-25-000080.md) | [0.0 d](/filings/0001341766-25-000104.md) | [1.7](/filings/0001341766-24-000093.md) | [0.6 d](/filings/0001341766-26-000024.md) | [1.9](/filings/0001341766-26-000039.md) | [0.9](/filings/0001341766-26-000050.md) | [0.4 d](/filings/0001341766-25-000144.md) | [2.5 d](/filings/0001341766-26-000024.md) | [8.8](/filings/0001341766-26-000039.md) | [1.0](/filings/0001341766-26-000050.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [75.8](/filings/0001341766-23-000035.md) | [236](/filings/0001341766-24-000029.md) | [237](/filings/0001341766-24-000057.md) | [237](/filings/0001341766-24-000093.md) | [238](/filings/0001341766-25-000080.md) | [238](/filings/0001341766-25-000104.md) | [234](/filings/0001341766-25-000144.md) | [237](/filings/0001341766-26-000039.md) | [260](/filings/0001341766-26-000050.md) | [258](/filings/0001341766-25-000144.md) | [260](/filings/0001341766-26-000039.md) | [257](/filings/0001341766-26-000050.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 253,035,047 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001341766-26-000050.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.